Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEFLAZACORT vs DELAVIRDINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DEFLAZACORT vs DELAVIRDINE: Safety Overview

Metric DEFLAZACORT DELAVIRDINE
Total FAERS Reports 3,831 142
Deaths Reported 149 5
Death Rate 3.9% 3.5%
Hospitalizations 592 3
Average Patient Age 25.7 yrs 50.7 yrs
% Female Patients 15.1% 5.2%
FDA Approval Date Apr 25, 2024 Apr 4, 1997
Manufacturer Cranbury Pharmaceuticals, LLC N/A
Route ORAL N/A
Marketing Status Prescription Discontinued